Cognitive decline in schizophrenia showed cognitive decline relative to controls over time, whereas SZA and BD demonstrated less pronounced cognitive changes, consistent with both neurodevelopmental and neurodegenerative models of psychotic illness.
Abstract
Background Patients with psychotic disorders often exhibit premorbid cognitive deficits and future cognitive changes following the onset of illness. This study examined cognitive trajectories in schizophrenia (SCZ), schizoaffective disorder (SZA) and bipolar disorder (BD) compared with healthy matched controls. Method Cases included individuals with SCZ (n = 24), SZA (n = 15), or BD (n = 11), and 50 controls matched for age, sex, and socioeconomic status (SES). Participants underwent IQ testing at age 17 as part of mandatory military screening (T1); the same tests were administered after illness onset (T2). Results Participants were assessed approximately 10 years after T1 (SD = 2.6). Cases with SCZ had a non-significant 4-point lower IQ than controls at T1. At T2, SCZ cases showed a 4-point IQ decline, whereas controls demonstrated a 5-point increase, resulting in a significant time × group interaction (F(1, 46) = 12.30, p = .006). At T2 the IQ of cases with SZ was 13 points lower than that of controls (96.97 ± 16.57 vs. 110.19 ± 11.87, respectively; Cohen's d = 0.91; p = .009). A similar trend was observed among cases with SZA and BD, although the magnitude was smaller and the interaction was non-significant. In SCZ, premorbid IQ was positively correlated with years of education (r = 0.670, p < .01), while IQ decline was associated with more psychiatric hospitalizations (r = −0.547, p < .01). Conclusion SCZ showed cognitive decline relative to controls over time, whereas SZA and BD demonstrated less pronounced cognitive changes. These findings are consistent with both neurodevelopmental and neurodegenerative models of psychotic illness.
This study investigates whether social cognitive deficits in bipolar disorder (BD) represent static susceptibility markers, underlying differences in severity and vulnerability or graded, stage-related differences, thereby testing the clinical staging hypothesis. A healthy control (HC; n = 97) group was utilized as a n...
E. Cesim, Yaren Ecesu Turan, Ö. İlhan et al.· European Neuropsychopharmaco...· 0 citations
INTRODUCTION
Catatonia is a neuropsychiatric syndrome associated with cognitive impairments, yet the neurocognitive performance of catatonia relative to other psychiatric disorders is poorly understood. This study characterised neurocognitive profiles in patients with a history of catatonia compared to schizophrenia sp...
Joseph M. Bianco, Joseph J. Cooper, Victor A. Valencia et al.· Cognitive Neuropsychiatry· 0 citations
DMPFC-somatomotor connectivity is longitudinally associated with cognitive performance in early psychosis, suggesting a novel, reliable target for intervention for cognitive deficits in early psychosis.
K. A. Mignondje, J. Connolly, A. Beermann et al.· medRxiv· 0 citations
OBJECTIVE
To investigate the joint associations of depressive symptoms and mild cognitive impairment (MCI) with longitudinal cognitive and clinical progression in Parkinson's disease (PD).
METHODS
A cohort of 487 non-demented Parkinson's disease patients was categorized into normal cognition without depressive sympto...
Tianyu Hu, Chenqing Xu, Yilin Tang et al.· Parkinsonism & Related Disor...· 0 citations
Improvements in group-level performance improved in six of the twenty tests administered, of which three remained significant after correction for multiple comparisons, while 28 of 42 patients (66.7%) still scored in the impaired range on at least one test at 12 months, and 17 (40.5%) on two or more.
Giulia Del Duca, M. Camici, Isabella Sperduti et al.· Neurology International· 0 citations
Impairments in processing speed and verbal learning are well documented in chronic schizophrenia and first episode psychosis (FEP), but the extent to which these patterns generalize to the clinical high-risk (CHR) stage remains less clear. A central interpretive challenge in CHR samples is the prominence of nonpsychoti...
Jonah Loshin, A. Culbreth, Abigail Stein et al.· Schizophrenia Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.